Related Experiment Video
Updated: Jun 26, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Symptomatic hypnic headache secondary to a nonfunctioning pituitary macroadenoma
Ivan Garza1, Kimberly Hall Oas
1Mayo Clinic-Neurology, Rochester, MN 55905, USA.
Headache
|January 31, 2009
Summary
Hypnic headache syndrome resolved after a patient underwent pituitary tumor removal. This rare headache disorder may be linked to pituitary abnormalities, warranting further investigation.
Area of Science:
- Neurology
- Endocrinology
- Oncology
Background:
- Hypnic headache syndrome is a rare primary headache disorder.
- Symptomatic cases of hypnic headache are increasingly reported in medical literature.
- The etiology of hypnic headache remains largely unknown.
Observation:
- A case study involving a female patient with hypnic headache syndrome is presented.
- The patient experienced resolution of hypnic headache symptoms post-surgery.
- The surgical intervention involved the removal of a pituitary tumor.
Findings:
- The successful removal of a pituitary tumor correlated with the cessation of hypnic headache symptoms.
- This case suggests a potential link between pituitary tumors and hypnic headache syndrome.
- Pituitary abnormalities may contribute to the pathophysiology of certain hypnic headache cases.
Implications:
- Pituitary tumor removal may be a therapeutic option for select hypnic headache patients.
- Further research is needed to elucidate the relationship between the pituitary gland and hypnic headaches.
- Brain neuroimaging, particularly magnetic resonance imaging (MRI), should be considered in the diagnostic workup of hypnic headache.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...